Yi-Hao Yen

33PUBLICATIONS
17CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicinePredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 28, 2026
Risk Group Stratification for True Early Recurrence After Ablation for Hepatomas.

|May 13, 2026
Sustained virological response improved survival outcomes after curative resection in patients with hepatitis C virus-related hepatocellular carcinoma in the era of direct‑acting antiviral therapy.

|May 13, 2026
Prognostic Significance of Histologic Steatotic Liver Disease in Curatively Resected Non-B, Non-C Hepatocellular Carcinoma.

|Apr 08, 2026
Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular Carcinoma.

Yi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung

|Jan 19, 2026
Antiviral therapy is associated with achievement of statistical cure of patients undergoing liver resection for hepatocellular carcinoma: a retrospective study.

Yi-Hao Yen, Sin-Hua Moi, Yueh-Wei Liu

|Oct 17, 2025
The association between antiviral therapy and 10-year overall survival of patients undergoing liver resection for hepatitis C virus- or hepatitis B virus-related hepatocellular carcinoma.

Yi-Hao Yen, Yueh-Wei Liu, Chien-Hung Chen

Pageof 6

Frequent Collaborators

6 joint publications

Chao-Hung Hung

5 joint publications

Chien-Hung Chen

5 joint publications

Ming-Chao Tsai

4 joint publications

Sheng-Nan Lu